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Abstract   
 
Background: Breast cancer remains the most common cancer in 
women worldwide. Interestingly, breast cancer incidence varies 
dramatically among countries. Japan, in particular, has relatively low 
breast cancer (BC) rates when compared to those in Western 
countries. Daily consumption of seaweed has been proposed as one of 
the factors in explaining the difference in incidence rates of BC. The 
high concentrations of polysaccharides in seaweed have been reported 
in many studies to have anti-cancer effects as well as chemoprotective 
effects. The aim for this review is to look at the potential benefits of 
seaweed consumption and its effect on breast cancer.  
 
Methods:  Exhaustive search of available medical literature was 
performed using MEDLINE-Ovid, Science Direct, Web of Science and 
CINAHL. Keywords used included: breast cancer, breast neoplasm and 
seaweed. Studies were assessed for quality using GRADE criteria. 
 
Results:  The systematic literature search yielded 311 articles for 
review. After screening the titles and abstracts, 3 articles met the 
eligibility criteria. Two of the studies were randomized control trials 
and 1 was a case-control observational study. These studies showed 
an association between seaweed consumption and lower rates of 
breast cancer.  
 
Conclusion: Daily consumption of seaweed may play an important 
role in decreasing the incidence of breast cancer in women.  
 
Keywords: Seaweed, breast cancer, breast neoplasm 
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Seaweed Consumption and Its Effect on  
Breast Cancer  
 
BACKGROUND 
Breast cancer remains the most common cancer in women 
worldwide. Interestingly, breast cancer incidence varies dramatically 
among countries. The biggest consumers of seaweed today are in Asia 
and include Japan, China, Korea, and the Philippines.1 Japan, in 
particular, has relatively low breast cancer (BC) rates when compared 
to those in Western countries. When comparing rates of BC between 
Japan and the United States, the rates are much higher in the US. 
According to the US Cancer statistics 2008 working group, the average 
BC incidence rates in US women is 118 per 100 000, whereas Japan 
has an average of 20 per 100 000.2 Although genetic predisposition 
has been proposed as part of BC susceptibility, this difference is also 
thought to be related to dietary preferences. Seaweed, in particular, 
has been proposed as one of the dietary factors in explaining the lower 
rates of BC in Japan. 
Seaweed is consumed on a daily basis in traditional Japanese 
diets. It is often incorporated in different types of meals such as 
soups, garnishes, teas, sauces, or salads. It is estimated that an 
average person in Japan consumes about 7.3 grams of seaweed per 
day.3 The high contents of polysaccharides in seaweeds have been 
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suggested to have anti-cancer effects.4 Fucoidan, a natural 
polysaccharides found in brown seaweed Laminaria, has been shown 
to inhibit cancer growth through induction of cell cycle arrest and 
apoptosis.5 In addition to it’s anti-cancer effects, fucoidan has also 
been shown to have a protective effect against the toxicity associated 
with chemotherapy and radiation. Ikegushi et al examined the effect of 
fucoidan on colorectal cancer patients who received 5-fluorouracil as 
part of their treatments. The group of patients who received 6 months 
of liquid fucoidan reported no side effects such as allergic dermatitis 
from chemotherapy. They also reported significant decrease in 
generalized fatigue from 60% to 10% when compared to the control 
group.8  
Thus, there is considerable interest in associations between high 
seaweed consumption and breast cancer risk. The aim for this review 
is to evaluate the benefits of seaweed consumption and its protective 
effects against breast cancer. 
 
 
METHODS 
A comprehensive literature search was completed using 
MEDLINE-Ovid, Science Direct, Web of Science and CINAHL. 
Completion of the search was done using the terms “breast cancer”, 
9 
 
“breast neoplasm”, “seaweed” and “study”. The titles and abstracts 
from the search were evaluated for inclusion based on eligibility 
criteria. The references from relevant articles were also evaluated for 
inclusion. The eligibility criteria consisted of literature assessing 
seaweed and its effects on breast cancer on human subjects, use of 
the English language, and study completion within the last 15 years. 
Literature included in the review were evaluated for quality of evidence 
using the Grading of Recommendations, Assessment, Development 
and Evaluation (GRADE) Working Group Guidelines.6 The level of 
evidence from each article was downgraded as needed based on its 
limitations, indirectness, inconsistency, imprecision and publication 
bias. Additional evaluation for observational studies included quality 
upgrades based on large magnitude of effects, dose-response gradient 
and plausible confoundings. 
 
RESULTS 
 The systematic literature search yielded 311 articles for review. 
After screening the titles and abstracts and eliminating duplicates, 3 
articles met the eligibility criteria and were included in the review. 
There were two randomized control trials8, 9 and one case-control 
observational study4 (See Table 1). The search yielded multiple studies 
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which evaluated the effects of seaweed on breast cancer but the 
subjects were non-human leading to the exclusion of these studies 
from the review.   
Yang et al 
 Yang et al4 is a retrospective observational study evaluating the 
relationship between seaweed consumption, specifically gim and 
miyeok--which are the 2 most common types of seaweed consumed in 
Korea--and the risk of breast cancer. The study participants included 
362 Korean women between the ages of 30-65 years. Cases and 
controls were recruited between October 2004 through June 2006. 
Cases included Korean women who were histologically confirmed to 
have breast cancer and controls were patients recruited from other 
clinics within the same hospital. Both cases and controls were 
interviewed by questionnaires about their “general characteristics, 
menstrual and reproductive history, family history of breast cancer, 
smoking and drinking habits, intake of multivitamins, the average time 
spent on exercising“ and dietary intake. Dietary intake was collected 
by a food frequency questionnaire (FFQ) which included 121 food 
items, 2 of which were gim and miyeok.4 
The amount of gim consumed was evaluated by quintiles and 
frequency and the amount of miyeok consumed was evaluated by 
quartiles and frequency as there was not enough miyeok consumed to 
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group them into quintiles. From the data collected, 3 models of 
comparison were used to evaluate the relationship between seaweed 
consumption and the risk of breast cancer. The study first assessed 
the quintiles of gim intake and the quartiles of miyeok intake with the 
risk of breast cancer. The first model did not apply any adjustments. 
The second model applied adjustments to variables that were 
significantly different which included multivitamin intake, number of 
children, breastfeeding, education, exercise and oral contraceptive use 
resulting in an OR of 0.43 (95% CI, 0.26, 0.70) for the last quintile (P 
for trend, 0.002).4 The third model adjusted further dietary factors 
which included consumption of energy, ß-carotene, vitamin C, folate, 
vitamin E, and soya protein. After adjustments of the confounding 
factors, an inverse correlation between gim intake by quintiles and the 
risk of breast cancer was seen within all 3 models (OR, 0.47; 95% CI. 
0.29, 0.75 for the last quintile in comparison with the lowest quintile; 
P for trend, 0.003). The frequency of gim intake was also analyzed 
with the same 2 models. The first 2 models also showed an inverse 
relationship with the risk of breast cancer and gim intake until the 
third model in which there was no significant relationship. The 
frequency and quartiles of miyeok intake did not show any correlation 
with the risk of breast cancer when analyzed within the 3 models 
above.4 
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Teas et al (2011) 
      Teas et al,8 a randomized control trial study, was completed to 
evaluate the relationship between seaweed and soy intake and levels 
of IGF-1. IGF-1 is an important biomarker associated with increased 
risk of postmenopausal breast cancer according to a meta-analysis 
done on 17 studies. The study participants included healthy 
postmenopausal women of European-American descent. Recruitment 
into the randomized, placebo-crossover study was done by word of 
mouth, physician referral, and newspaper ads. Of the 33 women who 
enrolled in the study, only 30 fit the inclusion criteria. Three women 
were excluded as they were currently on tamoxifen which is known to 
decrease IGF-1 levels.8  
 Thirty women were randomly assigned into placebo and 
treatment groups by a computer generator. The groups were divided 
into 5 g/day of seaweed powder (10 capsules) or 5 g/day of 
maltodextrin for 7 weeks.  During the 7th week of the 5 g/day of 
either seaweed or maltodextrin, participants were also required to take 
a daily soy supplement. After the 7 weeks there was a 3-week 
washout period followed by switching to the alternate treatment for an 
additional 7 weeks. At the end of each treatment period, fasting blood 
samples were taken for IGF-1 testing.8 
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 Analysis of the results was done using simple descriptive 
statistics. Of the 30 women, only 27 completed the entire study. The 
data from the first 3 collections of the 3 women who withdrew from 
the study was included in the end results. This was possible as the 
study met criteria for the intention-to-treat approach. Two withdrew 
due to mild side effects, 1 from gastroesophageal reflux and the other 
from a skin rash and itchy eyes. The third woman withdrew due to 
recommendations from her naturopathic provider.8  
 The end results yielded a significant difference in IGF-1 levels 
which increased based on whether they took the placebo or seaweed 
with soy. With placebo intake, the mean IGF-1 level was at 16.9 
nmol/L and increased by 25% when soy was added during the 7th 
week (21.2 nmol/L for soy vs 16.9 nmol/L for placebo; P = 0.0001). 
With seaweed and soy intake, the mean level of IGF-1 increase was 
reduced by about 40% (21.2 nmol/L for soy alone vs 19.4 nmol/L; P = 
0.01).8  
Teas et al (2013) 
 This randomized control study9 aimed to evaluate the effect of 
dietary seaweed on levels of urinary human urokinase plasminogen 
activator receptor (uPAR) in 15 healthy, postmenopausal American 
women. Increased concentrations of uPAR have been found to be 
associated with the rapid progression of BC. Participants, aged 50-66 
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years old, were recruited to a single-blinded placebo-controlled study 
for 3 months through Palmetto Health Tumor Registry.9  
All 15 participants had a negative mammogram for BC and did 
not consume dietary seaweed on a normal basis. Five who had never 
been diagnosed with BC were placed in a control group and the other 
10 were BC survivors who were placed in either an estrogen receptor 
positive (ER+) group or estrogen receptor negative (ER-) group. 
Participants ingested 10 capsules (5 g/day) of placebo (P1) filled with 
maltodextrin for 1-month, then seaweed (Undaria) for 1-month (S), 
followed by a placebo washout period (P2) for 1 month. Blood and 
urine samples were obtained at the end of each treatment period. The 
concentration of uPAR was then analyzed by ELISA. The evaluation of 
uPAR levels was used in this study as a possible biomarker for 
protective properties of seaweed against BC.9  
Following seaweed supplementation, all 3 groups showed a 
decreased in urinary uPAR concentrations by about 50%; however, the 
concentration was reversed after the second placebo treatment. P1, 
1.5 (95% CI, 0.9-2.1); S, 0.9 (95% CI, 0.6-1.1); and P2, 1.7 (95% 
CI, 1.2-2.2) 
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DISCUSSION 
Breast cancer has been one of the most prevalent cancers 
among women for many years. Despite the advances in early detection 
and treatment, it continues to take thousands of lives each year in the 
US. When comparing incidences of BC, there is a decrease in rates of 
breast cancer among women in Japan versus women in the US.9 This 
profound finding has been proposed to be caused by the differences in 
dietary intake, specifically seaweed. This has led to multiple studies 
evaluating the potential use of seaweed as an anti-cancer agent. 
According to the 3 studies in this systematic review, seaweed has been 
found to be a possible contributing factor in decreasing the risk of 
breast cancer. 
The first of the 3 articles reviewed, Yang et al,4 was a case-
control study looking at dietary intake of seaweed and the risk of 
breast cancer. The study overall was done well and took into 
consideration 3 models of adjustments to allow for confounding 
factors. Despite the adjustments, it is a retrospective observational 
study relying on patient recall which makes it less reliable. Participants 
were asked to recall their diet intake during a 12-month period within 
the last 3 years which may lead to inaccuracy of answers. The 
questionnaire used open ended questions which may lead to 
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differences in interpretation between participants. The population 
studied included a broad range of women between the ages of 30 and 
65 and was based in 1 hospital which may restrict the ability to apply 
findings to the general population. The article also did not include 
detailed information on data collection. The differences in diet between 
women who participated in the study and women who did not may 
also be another limitation. Yang et al4 only evaluated 2 types of 
seaweed and excluded others which are commonly consumed as well. 
Additional studies are needed to evaluate more types of seaweed 
consumed in various populations to be able to further evaluate its 
potential. The study found a significant relationship between gim 
intake and the decreased risk of breast cancer, but because it is a 
retrospective observational study, the correlation does not give a 
concrete relationship that seaweed consumption is the cause of 
decreased risk of breast cancer. Despite the limitations with Yang et 
al,4 the dose dependent relationship between gim intake and 
decreased risk of breast cancer is promising and warrants additional 
studies to further evaluate its potential.  
      The second article reviewed, Teas et al (2011),8 studied the 
effects of soy and seaweed consumption on IGF-1 levels. The study 
included a randomized, placebo-controlled crossover design. 
Treatment allocation was blinded with computer generation. All 
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participants began the study with the same prognostic variables 
including age, BMI, weight, physical exercise, parity, breast cancer 
treatments, and baseline IGF-1 levels. Despite the positive aspects of 
the study mentioned above, there were a few limitations affecting it’s 
quality. There was only a total of 30 women who completed the entire 
study. The small number of participants were of European-American 
descent and were recruited from Massachusetts limiting the 
applicability to those of Asian-Western descent. This would be 
important to include as the Asian diet, specifically Japanese and 
Koreans, most commonly include seaweed and soy in their diets. 
Including Asian-Americans in the study could possibly reveal further 
significant findings. Teas et al (2011)8 only included 1 type of 
seaweed, Alaria esculenta (L.), which can only be found in Ireland or 
Great Britain. This also limits the applicability of findings as this 
seaweed is not commonly consumed around the world. The dietary 
intake of the participants is unknown which can significantly affect the 
levels of IGF-1. IGF-1 levels are known to be affected by tomatoes, 
dairy and green tea. By evaluating their dietary intake, adjustments 
could be made if there are any significant differences in diets affecting 
the outcome. The end results overall yielded a significant difference 
depending on placebo or seaweed intervention. Although the baseline 
and follow up IGF-1 levels were all within normal range, there was a 
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reduction in the level of IGF-1 increase with seaweed. Despite the 
limitations, the results are promising and should be further studied 
with a larger sample size, inclusion of women from various 
backgrounds, and evaluation of other dietary factors.  
      The last article reviewed was another study done by Teas et al 
(2013).9 The study evaluated the effects of seaweed on urokinase-type 
plasminogen activator receptor (uPAR). The increased concentrations 
of uPAR have been associated with the presence of breast cancer and 
poorer prognosis.9 The study included a single-blinded, placebo-
controlled design but did not mention how treatment allocation was 
performed. Adherence to the treatment was maintained with clinic 
visits and urinary iodine testing. Participant demographics had no 
significant differences but there were some important differences with 
prognostic variables. Participants who had survived breast cancer had 
higher levels of FSH indicating possible variables in hormone levels 
which can affect outcomes. The study also tested the effects of only 1 
type of seaweed, Undaria pinnatifida, which is most commonly eaten 
in Japan. Only seaweed with the highest amounts of fucoidan, a 
component of seaweed found to have anti-cancer effects, was used in 
the study. This left out other common types of seaweed that are also 
commonly eaten in Japan. Dietary variables were also not included and 
could have affected the levels of uPAR tested. The study included a 
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small sample size of 15 participants limiting precision. The uPAR levels 
were found to decrease by about 50% with 5g/day of seaweed.  
      All 3 studies found significant relationships between seaweed 
consumption and the risk of breast cancer. They each evaluated a 
different type of seaweed making it difficult to determine which one is 
the most effective in decreasing the risk of breast cancer. Yang et al,4 
despite being a case-control study, had a significant dose response 
gradient. The following 2 randomized control trials8,9 had the same 
author leading to some publication bias and small sample sizes limiting 
their quality. Despite bias and small sample sizes, they both yielded 
interesting connections to cancer-related biomarkers which is 
promising for future studies. Although these studies support the 
potential use of seaweed consumption in decreasing the risk of breast 
cancer, further studies are needed before inclusion of seaweed in 
interventional practice. 
 
CONCLUSION 
 Although the potential benefits of seaweed need to be further 
investigated, the studies suggest that there is a direct association 
between seaweed consumption and a decreased risk of breast cancer. 
Such findings provide a possible explanation as to why the incidence of 
BC remains lower in the seaweed-consuming populations. However, 
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the vast variety of seaweeds as well as different ways that they are 
consumed make it difficult to estimate which type of seaweed and the 
actual daily intake it would require to obtain anti-cancer effects. It 
should also be noted that each species of seaweed is made up of 
different biochemical compositions. Thus, the effects reported in the 
studies only applied to particular types of seaweed, Porphyra sp and 
Undaria.  Although the mechanisms in how seaweed provides 
protective effects against breast cancer is not fully understood, this 
review has compiled some evidence that seaweed could play a critical 
role as a source of anti-cancer agent.  
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Table 1: Quality Assessment of Reviewed Articles 
Outcome Number 
of 
studies 
Study 
Designs 
Downgrade Criteria Upgrade 
Criteria 
Quality 
Limitations Indirectness Inconsistency Imprecision Publication 
bias 
Risk of 
Breast 
Cancer 
1 Observation Not 
serious 
Not Serious Not Serious Seriousa Not likely Dose-
Response 
Gradient 
Very Low 
IGF-1 levels 1 RCT Not 
serious 
Seriousb Not Serious Seriousa Likelyc None Very Low 
uPAR levels 1 RCT Not 
serious 
Seriousb Not serious Seriousa Likelyc None Very Low 
a Small sample size 
b Reliance on surrogate outcomes 
c Same authors published both RCTs. 
 
 
 
 
